Coolgardie (as at Apr-2017 - proactive investors source):
- Resource @ 5.89 million tonnes at 2.5 g/t gold for 475,500 ounces of contained gold.
- Includes The Brilliant Project, a historical gold deposit which forms part of the company’s tenement portfolio in the highly prospective
- Coolgardie region of Western Australia.The deposit was a major open pit gold producer, mined in stages from 1970’s to early 2000’s with total production of circa 88,000 ounces of gold at an average grade of 2.45 g/t gold.
From FML 2017 Annual Report:
- PFS for the Coolgardie project: +4yrs Mine Life averaging 32koz PA at all in Cash cost of AU$1,200/oz
- PFS NPV of AU$37M assuming gold price of AU$1580/oz and 7.5% Discount rate
Question: if Coolgardie has 475k oz @ 2.5g/t (as per link above), then why is the PFS a 4yr LOM averaging 32koz per annum? 475k / 32K is more than 4yr mine life. Is that because PFS' are based on measured and indicated only?
- Forums
- ASX - By Stock
- HRZ
- Ann: Intermin Signs Exclusivity Deed for potential acquisition
Ann: Intermin Signs Exclusivity Deed for potential acquisition, page-8
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HRZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
-0.002(5.41%) |
Mkt cap ! $39.14M |
Open | High | Low | Value | Volume |
3.6¢ | 3.6¢ | 3.4¢ | $33.54K | 964.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 483673 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 50893 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 483673 | 0.034 |
2 | 640000 | 0.033 |
1 | 15153 | 0.032 |
3 | 369720 | 0.031 |
7 | 579239 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 50893 | 3 |
0.038 | 25427 | 1 |
0.041 | 156306 | 1 |
0.043 | 200000 | 1 |
0.044 | 25150 | 2 |
Last trade - 14.00pm 15/07/2024 (20 minute delay) ? |
Featured News
HRZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online